在人口中使用预后模型预测与肝脏有关的重大事件
Fredrik Åberg1, Ville Männistö2,3
1Transplantation and Liver Surgery Unit, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Gastroenterology report
|March 17, 2025
概括
像CLivD,daAR和CORE这样的新风险评分直接预测肝脏相关事件 (LREs),提供比纤维化重点模型更好的早期检测,以积极管理肝脏疾病.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 预防医学 预防医学
- 生物统计学 生物统计学
背景情况:
- 肝病,特别是脂肪性肝病,是全球主要的健康问题.
- 目前的策略侧重于先进的纤维化检测以进行风险分层,但这并不总是预测即将发生的结果.
- 对于能够直接预测肝脏相关事件 (LREs) 进行及时干预的模型,有极大的需求.
研究的目的:
- 评估专门设计用于预测LRE的风险分层模型.
- 为了比较以LRE为重点的模型与以纤维化为重点的模型来预测不良肝脏结果.
- 突出将LRE预测模型纳入临床实践的实用性.
主要方法:
- 专门用于LRE预测而开发的风险模型的分析:慢性肝病 (CLivD) 评分,动态阿斯巴酸胺转移酶与氨酸胺转移酶比率 (dAAR) 和肝硬化结果风险估计器 (CORE).
- 与最初用于纤维化检测 (例如,Fibrosis-4,LiverRisk,LiverPRO) 开发的模型进行比较,但后来用于LRE预测进行分析.
- 用标准肝酶或风险因素评估来自一般人口队列的模型.
主要成果:
- 与以纤维化为重点的模型不同,CLivD,daAR和CORE的设计专门用于预测LREs.
- 这些以LRE为重点的模型在初级保健和人口环境中广泛适用.
- 将LRE预测模型与纤维化查相结合,可以增强主动和预防性护理策略.
结论:
- 像CLivD,daAR和CORE这样的模型提供了直接方法来预测LREs,改进了传统的纤维化中心方法.
- 这些以LRE为重点的模型适用于广泛的临床应用,有助于早期风险识别.
- 将纤维化评估与LRE风险预测相结合,可以更好地管理患者和分配肝脏疾病的资源.
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
401
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
401
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
275
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
275